Nippon Shinyaku Co., Ltd. (TYO:4516)
3,423.00
+23.00 (0.68%)
Aug 3, 2026, 3:30 PM JST
Nippon Shinyaku Market Cap
Nippon Shinyaku has a market cap or net worth of 230.71 billion as of August 3, 2026. Its market cap has increased by 3.67% in one year.
Market Cap
230.71B
Enterprise Value
157.01B
Revenue
170.77B
Ranking
n/a
PE Ratio
7.76
Stock Price
3,423.00
ChartMarket Cap Chart
Since August 18, 1993, Nippon Shinyaku's market cap has increased from 96.59B to 230.71B, an increase of 138.85%. That is a compound annual growth rate of 2.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 230.71B | -39.42% |
| Dec 30, 2025 | 380.82B | 41.69% |
| Dec 30, 2024 | 268.77B | -20.13% |
| Dec 29, 2023 | 336.49B | -33.21% |
| Dec 30, 2022 | 503.80B | -6.62% |
| Dec 30, 2021 | 539.50B | 18.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sumitomo Pharma | 559.84B |
| Tsumura & Co. | 284.54B |
| Towa Pharmaceutical | 197.16B |
| Sawai Group Holdings | 190.61B |
| Kissei Pharmaceutical | 169.33B |
| Kaken Pharmaceutical | 143.71B |
| Mochida Pharmaceutical | 110.51B |
| Zeria Pharmaceutical | 92.13B |